[1] 周方. 股骨颈骨折治疗的热点与创新[J]. 中华创伤骨科杂志, 2021, 23(9): 742-747 [2] Assaf E, Bdeir M, Mohs E, et al.Singleton-Merten syndrome: A rare cause of femoral head necrosis[J]. Am J Med Genet A, 2021, 185(10): 3170-3175. [3] Liu Y, Li J, Gao Y, et al.Primary repair for concurrent bilateral intertrochanteric fracture and femoral head necrosis with prolonged shank biologic total hip replacement: A case report and surgical techniques[J]. Chin J Traumatol, 2023, 26(3): 183-186. [4] Gabalski AH, Tynan A, Tsaava T, et al.Circulating extracellular choline acetyltransferase regulates inflammation[J]. J Intern Med, 2024, 295(3): 346-356. [5] Chi Z, Wang S, Zhao D, et al.Evaluating the Blood Supply of the Femoral Head During Different Stages of Necrosis Using Digital Subtraction Angiography[J]. Orthopedics, 2019, 42(2): e210-e215. [6] Adekile AD, Gupta R, Al-Khayat A, et al.Risk of avascular necrosis of the femoral head in children with sickle cell disease on hydroxyurea: MRI evaluation[J]. Pediatr Blood Cancer, 2019, 66(2): e27503. [7] Lin X, Tang J, Liu C, et al.Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study[J]. BMC Anesthesiol, 2020, 20(1): 246. [8] Fujisawa K, Hirata H, Inada H, et al.Value of a dynamic MR scan in predicting vascular ingrowth from free vascularized scapular transplant used for treatment of avascular femoral head necrosis[J]. Microsurgery, 1995, 16(10): 673-678. [9] 中华医学会骨科学分会创伤骨科学组, 中国医师协会骨科医师分会创伤专家工作委员会. 成人股骨颈骨折诊治指南[J]. 中华创伤骨科杂志, 2018, 20(11): 921-928. [10] Chandrinou A,Korompeli A,Grammatopoulou E,et al.Avascular necrosis of the femoral head:Evaluation of hyperbaric oxygen therapy and quality of life[J]. Undersea Hyperb,2020,47(4):561-569. [11] 周泽旺, 冷西, 曾道辉, 等. IVIM-DWI与定量DCE-MRI对股骨头坏死微循环的评价及与ARCO分期的相关性[J]. 临床放射学杂志, 2022, 41(2): 303-308 [12] Kimura N, Shiga K, Kaneko K, et al.Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas[J]. Endocr Pathol, 2021, 32(4): 442-451. [13] 胡婧, 张英英, 江哲珍, 等. 个案管理模式在股骨头坏死显微治疗中的护理效果评价[J]. 中华显微外科杂志, 2021, 44(6): 690-693 [14] Abdel AN, Elkady AA, Elgazzar EM.et al[J]. Choline glycerophosphate and silymarin modulate brain and intestinal injuries in rats exposed to gamma-radiation[J]. Int J Radiat Res, 2022, 20(4): 829-837. [15] 张瑾峰, 贾俊青, 顾晓东, 等. 股骨颈骨折后股骨头坏死影响因素研究进展[J]. 临床误诊误治, 2024, 37(17): 86-91. [16] Bagwep V, Sathaye S.Significance of Choline Acetyltransferase Enzyme in Tackling Neurodegenerative Diseases[J]. Curr Molecul Biol Rep, 2022, 8(2): 9-22. [17] Kotsyuba E, Dyachuk V.Localization of neurons expressing choline acetyltransferase, serotonin and/or FMRFamide in the central nervous system of the decapod shore crab Hemigrapsus sanguineus[J]. Cell Tissue Res, 2020, 383(3): 959-977. [18] Yang Q, Li L, Zha Y, et al.Microvascular Permeability and Texture Analysis of the Skeletal Muscle of Diabetic Rabbits With Critical Limb Ischaemia Based on DCE-MRI[J]. Front Endocrinol (Lausanne), 2022, 13: 783163. [19] 陈绍宁, 魏冰. 动态对比增强磁共振成像与股骨头坏死患者病程进展关系及疗效评估价值[J]. 广东医学, 2022, 43(2): 226-230. [20] Zheng LW, Wang WC, Mao XZ, et al.TNF-α regulates the early development of avascular necrosis of the femoral head by mediating osteoblast autophagy and apoptosis via the p38 MAPK/NF-κB signaling pathway[J]. Cell Biol Int, 2020, 44(9): 1881-1889. [21] Krishnan Y, Grodzinsky AJ. Cartilage diseases [J]. Matrix Biol, 2018, 71: -72:51-69. [22] Seijas R, Sallent A, Rivera E, et al.Avascular Necrosis of the Femoral Head[J]. J Invest Surg, 2019, 32(3): 218-219. [23] Xia W, Zhang A, Qiu B, et al.Femoral neck fracture after femoral head necrosis: a case report and review of the literature[J]. BMC Musculoskelet Disord, 2023, 24(1): 853. [24] Celiksoz A, Kavak M, Tarlacık AO.Inflammatory Index as a Predictor of Mortality in Elderly Patients With Intracapsular Femoral Neck Fracture[J]. Cureus, 2023, 15(10): e46318. [25] Kondo H, Okimoto N, Yoshioka T, et al.Zoledronic acid sequential therapy could avoid disadvantages due to the discontinuation of less than 3-year denosumab treatment[J]. J Bone Miner Metab, 2020, 38(6): 894-902. |